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Introduction 
Australia’s absolute cardiovascular disease (CVD) risk assessment algorithm1 first examines 
whether individuals meet criteria for clinically determined high CVD risk and, in those not 
meeting these criteria, applies the Framingham Risk Equation to estimate an individual’s risk 
of having a CVD event in the next 5 years. The same risk equation is used for Aboriginal and 
Torres Strait Islander people and non-Indigenous Australians, although there is variation in 
underlying risk across the two populations, with the former experiencing a greater burden of 
cardiovascular risk factors. 
Three main clinical CVD guidelines in Australia provide recommendations on assessing 
and managing CVD risk in Aboriginal and Torres Strait Islander people.1-3 All recommend 
using a similar CVD risk assessment algorithm, although recommendations differ in relation 
to the age at which CVD risk assessment should start for Aboriginal and Torres Strait 
Islander people and whether an additional 5% loading should be added to estimated risk 
scores. These recommendations are primarily based on expert opinion or, in some 
circumstances, evidence and recommendations from previous New Zealand guidelines.4 
Other international guidelines, such as those of Canada5 and the US6, acknowledge the 
increased risk of CVD in Indigenous populations without providing specific recommendations 
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for these populations. Evidence from Aboriginal and Torres Strait Islander populations is 
essential for ensuring that guideline recommendations for this population are evidence 
based and fit for purpose. The aim of this study was to systematically review recently 
published primary data on the targeting of, and methods to assess and manage, absolute 
CVD risk in Aboriginal and Torres Strait Islander people. 
Methods 
Studies published from 31 December 2010, since the development of the national CVD 
guidelines1, to 18 October 2017 were identified using systematic searches of MEDLINE and 
Scopus, supplemented with forward and backward citation searches of the included studies. 
The predefined protocol was published in PROSPERO (CRD42017079181). Search terms 
were “cardiovascular”, "heart disease", "coronary heart disease", "cardiovascular system", 
“stroke”, “cerebrovascular disease”, “myocardial infarction”, “ischaemic heart disease“, 
“peripheral vascular disease”, “Indigenous”, “Aboriginal”, “Torres Strait Islander” and 
“Australia”; and combinations of "risk", “prediction”, “model”, “score”, “assessment”, 
“management”, “primary”, “prevention” and “control”.  
Studies were included if they related to Aboriginal and/or Torres Strait Islander absolute 
CVD risk assessment and/or treatment, reported primary data, and included participants 
without existing CVD. Studies were excluded if they only reported results for people with 
existing CVD or did not separately report results for people without CVD, only included 
pregnant women or children, reported the development or testing of electronic decision 
support tools, or reported only the coverage of CVD risk assessment. In addition, we 
identified studies meeting the selection criteria that were published before 2010, cited in 
national CVD risk assessment guidelines.1 
Data were extracted using a prespecified template and were checked independently by a 
second investigator. Study quality (good, fair or poor), including an assessment of the risk of 
bias, was independently assessed by two investigators, and discrepancies were resolved by 
adjudication by a third investigator. Quality was assessed using the Quality Assessment Tool 
for Observational Cohort and Cross-Sectional Studies from the National Heart, Lung and 
Blood Institute in the US. 
Results 
We identified 205 abstracts through our search strategy, of which 32 were eligible for full-text 
review. Of these, 14 did not report absolute CVD risk, three did not separately report results 
for people without CVD, four were study protocols or cohort profiles, five were reviews or did 
not contain primary data, and one reported only the coverage of CVD risk assessment. Five 
articles met our inclusion criteria. Studies included Aboriginal and/or Torres Strait Islander 
people (age range 18–76 years) from the Northern Territory7-10, Queensland10,11, Western 
Australia10 and South Australia.10 Approximately equal numbers of men and women were 
included, and all studies were of fair or good quality.  
Two studies described absolute CVD risk profiles in Aboriginal and Torres Strait Islander 
communities.9,10 High absolute CVD risk commenced at an early age, with approximately 6–
9% of those aged 20–34 years having moderate (10–15% over 5 years) or high (>15% over 
5 years) absolute CVD risk.9,10 
There was evidence that the Framingham Risk Equation underestimated CVD risk by 
around 1.5–2.5 times when used alone, without applying criteria for clinically determined 
high risk.8,11 In the study by Wang and Hoy, observed rates of coronary heart disease were 
estimated at 11 cases per 1000 person-years compared with a predicted rate of 4.4 per 
1000 person-years estimated using the Framingham Risk Equation.8 In the study by Hua 
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and colleagues, the probability of CVD events was 10% compared with a predicted 
probability of 6.8%.11  
Two studies reported on the development of CVD risk scores for Aboriginal and Torres 
Strait Islander people, using age and waist circumference as predictors7 or recalibrating the 
existing Framingham Risk Equation.11 The first study developed simplified, sex-based charts 
for absolute 10-year CVD risk based on age and waist circumference.7 Although waist 
circumference was found to be a better predictor of CVD than measurements of body mass 
index and waist-to-hip ratio, it is unclear whether these models perform better than those in 
current use, because they were not compared with the Framingham Risk Equation.7 The 
rationale for using such simplified models in settings where direct measurements are readily 
available relevant to blood pressure, diabetes and cholesterol – the main ways in which 
adiposity affects CVD risk – is also not clear.  
In the second study11, the recalibrated score improved the ability to discriminate between 
people with and without CVD. However, the approach did not account for people at clinically 
determined high risk and was not externally validated.  
Discussion 
Overall, there is a dearth of empirical evidence to inform recommendations in Australian 
clinical guidelines for CVD risk assessment and management in Aboriginal and Torres Strait 
Islander people. Available evidence suggests that CVD risk starts early in Aboriginal and 
Torres Strait Islander people, and that the Framingham Risk Equation alone may 
underestimate CVD risk, at least in communities in remote northern Australia.8,11 However, 
the algorithm used in national guidelines first categorises people with certain clinical 
conditions as being at high absolute CVD risk, and then only applies the Framingham Risk 
Equation to people without these conditions. Evidence published after the cut-off date for this 
review suggests that more than 75% of Aboriginal and Torres Strait Islander people 
classified as being at high risk are classified as such based on clinical criteria, rather than 
using the Framingham Risk Equation.12 Therefore, there is no direct evidence on whether 
the algorithms in use underestimate Aboriginal and Torres Strait Islander CVD risk. It is also 
unclear how the Framingham Risk Equation performs in other communities. Risk scores 
should be calibrated specifically for the target population; although the study by Hua and 
colleagues11 did this, this study has limited applicability and generalisability.  
The paucity of evidence in this review highlights the need for more empirical evidence to 
inform guidelines. Additional evidence from data collation efforts across existing studies, 
such as the ongoing study on Cardiovascular Disease Risk Prediction in Indigenous 
Australians, will be informative for risk estimation, although limitations relating to sample size 
and generalisability remain. The main determinant of absolute CVD risk is the underlying 
age- and sex-specific hazard for the relevant population. Therefore, representative data on 
age- and sex-specific CVD incidence can be used to recalibrate risk scores to more 
accurately estimate risk in the target population. Hua and colleagues attempted to do this 
using CVD rates estimated from a cohort of participants from the Well Person’s Health 
Check in remote Far North Queensland.11 Broader use of these findings is limited by the use 
of the Framingham Risk Equation without preceding categorisation into high-risk groups 
using clinical criteria, and issues with generalising the results from this regional primary care 
population to other Aboriginal and Torres Strait Islander populations. An alternative, 
pragmatic and probably more generalisable approach is to use national statistics on 
Aboriginal and Torres Strait Islander CVD incidence rates, when linked hospital and mortality 
data become available, to revise the relevant algorithm, including recalibrating the 
Framingham Risk Equation and adjusting the risk threshold.13  
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Conclusion 
There is currently little empirical evidence to inform national guidelines on the assessment 
and management of absolute CVD risk in Aboriginal and Torres Strait Islander people. 
Reducing CVD morbidity and mortality in Aboriginal and Torres Strait Islander people 
requires evidence-based guidelines, applying the best contemporary data to the issue and 
gathering new data. 
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